<DOC>
	<DOCNO>NCT00692289</DOCNO>
	<brief_summary>This open label , non-interventional quality life analysis Arimidex treat postmenopausal patient early breast cancer investigator 's questionnaire</brief_summary>
	<brief_title>Quality Life Analysis Arimidex Treatment Postmenopausal Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Provision inform consent Postmenopausal , hormon receptor positive patient early breast cancer treat Arimidex Investigators request recruit patient least 1 month prior Arimidex treatment . Allergy substance medication Preperimenopausal woman Woman eligible treatment</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Quality Life</keyword>
</DOC>